HIGHLIGHTS
- who: Raquel, Chiles and Rami A., Al-Horani from the Division of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, LA, USA have published the research: Vericiguat: A New Hope for Heart Failure Patients, in the Journal: Cardiovascular ue020erapeutics of 17/Dec/2022
- what: HFrEF is a debilitating, chronic, and progressive disease.
SUMMARY
Heart failure can be chronic and progressive, and despite recent advances, patients with symptomatic heart failure have very poor prognosis. Heart failure with reduced ejection fraction (HFrEF), which is also widely known as systolic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.